RESOLUTIONS UNANIMOUSLY PASSED AT THE EXTRAORDINARY MEETING OF SHAREHOLDERS OF OBDUCAT AB (PUBL) ON APRIL 15, 2005

At Obducat AB’s Extraordinary Meeting of shareholders on April 15, 2005 the following resolutions were adopted:

· The Meeting unanimously approved the Board’s decision to implement, during the month of May, a new share issue with preferential rights principally on the following terms and conditions:

Cash issue with preferential rights 2:7, implying that a maximum amount of 1.857.142 new series A shares and a maximum amount of 56.777.018 new series B shares could be issued. The issue price shall amount to SEK 1,06, corresponding to 75 per cent of the average exchange quotation of the Company’s series B shares at NGM Equity each trading day during the period commencing April 1, 2005 up to and including April 14, 2005. The record day entitling to subscription of shares in the share issue is April 26, 2005. The subscription period shall extend from May 9 to 23, 2005.

· The Meeting unanimously authorised the Board to, prior to the next Annual General Meeting, on one or several occasions resolve to implement a new share issue of a maximum of 80.000.000 series B shares, and to decide to waive the shareholder’s preferential rights. The issue price of the new shares shall amount to a minimum of 105 per cent of the issue price in the preferential rights issue proposed above, corresponding to SEK 1,12. The reason for the authorisation is mainly to facilitate new share issues directed at one or several Swedish or foreign investors. Fully exercised the authorisation would correspond to a dilution effect of approx. 28 per cent of the share capital and voting rights and, in the case of full utilisation of current warrants and full conversion of current convertible debenture loans, approx. 23 per cent. The dilution has been calculated on the number of additional shares after full utilisation of the authorisation divided by the total amount of shares in the company after full utilisation. The calculation has been made without taking into consideration the effect of the preferential rights issue proposed above.

· The Meeting unanimously approved the proposed amendment to the Articles of Association, which were subsequently supplemented with a stipulation in respect of simplified procedures for the re-stamping of shares from series A to series B.

At the Meeting the special examination report, which was resolved at the Annual General Meeting 2004, was formally presented. The special examiner, Joakim Edoff, lawyer at Setterwalls Advokatbyrå, presented the report.

CEO Patrik Lundström concluded in his presentation that Obducat, under certain stated conditions, has the possibility to increase turnover from MSEK 50-70 this year up to MSEK 800-1,200 in 2009. The Chairman Henri Bergstrand indicated a related need of some MSEK 100 in additional funding during 2006.

For further information please contact:

Henri Bergstrand, Chairman, +46 708 88 72 45

Patrik Lundström, CEO, +46 40 36 21 00 or +46 703 27 37 38

Obducat AB is an innovative developer and supplier of technologies, products and processes used for the production and replication of advanced micro and nano structures. Obducat’s products and services are intended to serve the demands of companies within the information storage, semiconductor, printed circuit board, and sensor industries. Obducat’s technologies include electron beam and nano imprint technology. Obducat has offices in Sweden and the UK, with the head quarters located in Malmö, Sweden. The Obducat shares are publicly traded on the Swedish NGM stock exchange.

Read more at www.obducat.com